1. Gadour MO, Salman AH, El Samman el Tel W, et al. Ménétrier’s disease: an excellent response to octreotide. A case report from the Middle East. Trop Gastroenterol. 2005;26:129–131.
2. Green BT, Branch MS. Ménétrier’s disease treated with octreotide long-acting release. Gastrointest Endosc. 2004;60:1028–1029. doi: 10.1016/S0016-5107(04)02215-1 .
3. Yeaton P, Frierson HF Jr. Octreotide reduces enteral protein losses in Ménétrier’s disease. Am J Gastroenterol. 1993;88:95–98.
4. Coffey RJ, Washington MK, Corless CL, et al. Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80. doi: 10.1172/JCI30491 .
5. Lee EL, Feldman M. Gastritis and gastropathies. In: Feldman M, Friedman LS, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 8th edn. Philadelphia: Saunders; 2006:1068–1088.